Lincoln Pharmaceuticals

564.45
-6.70
(-1.17%)
Market Cap
1,130.58 Cr
EPS
46.58
PE Ratio
12.76
Dividend Yield
0.32 %
Industry
Healthcare
52 Week High
979.50
52 Week low
534.80
PB Ratio
1.78
Debt to Equity
0.00
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
15.43 %
Net Income Growth
27.98 %
Cash Flow Change
61.03 %
ROE
8.48 %
ROCE
2.31 %
EBITDA Margin (Avg.)
4.20 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
79
73
91
105
129
93
78
74
119
152
93
83
68
102
107
85
78
98
115
102
83
106
127
116
82
124
131
123
105
130
146
140
116
143
165
158
150
158
171
156
Expenses
71
64
84
95
117
74
63
62
115
143
74
64
58
77
84
71
68
78
88
85
70
82
96
95
64
97
98
96
85
107
112
107
96
115
125
117
124
125
133
123
EBITDA
7
9
8
10
12
19
15
12
4
10
18
19
11
26
24
14
10
20
27
16
13
24
30
21
18
27
33
26
19
23
35
33
21
28
40
41
25
33
38
33
Operating Profit %
9 %
12 %
8 %
9 %
3 %
17 %
16 %
12 %
3 %
5 %
17 %
20 %
14 %
23 %
19 %
16 %
14 %
20 %
22 %
13 %
11 %
21 %
24 %
17 %
19 %
21 %
23 %
20 %
17 %
14 %
21 %
20 %
15 %
15 %
20 %
20 %
13 %
15 %
18 %
16 %
Depreciation
1
1
1
1
1
1
1
2
1
1
2
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
Interest
3
2
2
2
4
2
2
1
1
2
2
1
1
1
2
1
1
1
1
1
-1
1
-0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
1
Profit Before Tax
3
8
9
10
6
15
12
9
1
7
15
16
8
23
20
11
8
18
25
13
12
21
29
18
15
25
31
24
17
21
32
31
17
26
37
38
22
30
35
29
Tax
1
2
2
3
2
4
3
3
-0
2
4
5
1
7
5
2
-1
5
6
2
3
6
8
5
3
7
8
6
6
6
8
9
4
6
9
10
4
6
8
8
Net Profit
2
7
7
7
4
11
9
7
1
5
11
12
7
16
15
9
9
13
19
11
9
15
21
14
13
18
23
18
11
15
24
22
13
19
28
28
19
24
26
21
EPS in ₹
1.35
4.01
4.10
3.95
2.46
6.99
5.42
3.27
0.66
2.46
5.65
5.79
3.42
8.03
7.50
4.57
4.25
6.33
9.46
5.46
4.47
7.63
10.46
6.73
6.29
8.85
11.50
8.79
5.50
7.49
11.84
10.79
6.27
9.49
13.81
14.00
9.28
11.82
13.15
10.37

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
258
275
305
347
366
389
452
534
587
700
Fixed Assets
66
99
103
117
121
123
111
132
151
179
Current Assets
177
147
181
218
224
248
309
353
367
447
Capital Work in Progress
3
3
7
0
2
0
2
16
7
4
Investments
0
0
10
11
18
34
81
97
91
139
Other Assets
190
174
186
219
225
232
259
290
339
379
Total Liabilities
258
275
305
347
366
389
452
534
587
700
Current Liabilities
111
100
91
105
85
66
76
91
72
92
Non Current Liabilities
33
34
22
18
11
10
10
11
13
15
Total Equity
114
141
193
225
270
314
366
433
503
593
Reserve & Surplus
95
117
172
204
249
293
346
413
482
573
Share Capital
16
16
20
20
20
20
20
20
20
20

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
-0
4
-1
7
-1
-5
-2
1
Investing Activities
7
-42
-26
-12
-18
-31
-64
-78
-37
-57
Operating Activities
25
45
25
27
53
75
69
76
39
63
Financing Activities
-32
-3
0
-11
-36
-38
-6
-3
-5
-5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
37.26 %
37.78 %
40.28 %
42.08 %
42.05 %
44.08 %
44.08 %
46.34 %
47.00 %
48.67 %
50.53 %
49.80 %
49.53 %
49.78 %
49.78 %
49.78 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.59 %
0.00 %
3.93 %
3.95 %
5.19 %
5.16 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.04 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
42.89 %
40.52 %
40.20 %
38.88 %
38.68 %
39.12 %
39.12 %
36.61 %
37.03 %
37.32 %
37.47 %
37.78 %
37.36 %
37.10 %
36.14 %
36.71 %
Others
19.85 %
21.70 %
19.52 %
19.04 %
19.27 %
16.80 %
16.79 %
17.06 %
15.97 %
14.01 %
9.41 %
12.42 %
9.13 %
9.14 %
8.89 %
8.35 %
No of Share Holders
21,415
26,420
30,274
31,913
32,447
31,902
31,731
29,846
29,088
27,480
28,670
29,316
31,375
29,967
31,330
31,848

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1.2 1.5 1.5 1.5 1.5 1.5 1.5 1.8 0.00
Dividend Yield (%) 0.00 0.56 0.71 1.16 0.67 0.48 0.44 0.26 0.32 0.00

Corporate Action

Technical Indicators